» Articles » PMID: 28231480

Feasibility and Acceptability of Post-hospitalization Ecological Momentary Assessment in Patients with Psychotic-spectrum Disorders

Overview
Specialty Psychiatry
Date 2017 Feb 24
PMID 28231480
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Up to 50% of patients with psychotic-spectrum disorders are medication nonadherent. The use of real-time assessment via ecological momentary assessment (EMA) on mobile devices might offer important insights into adherence behaviors that cannot be measured in the clinic. However, existing EMA studies have only studied acutely ill patients during hospitalization or more stable patients in the community.

Methods: Feasibility and acceptability of EMA in 65 patients with psychotic-spectrum disorders who were recently discharged from the hospital were assessed. EMA was administered for four weeks via study-provided mobile devices. Feasibility was measured by study recruitment/retention rates, patients' connectivity, and completion rates. Quantitative and qualitative acceptability data were collected.

Results: Participants completed 28-31% of offered EMA assessments. The only significant predictor of reduced EMA completion was recent cannabis use. EMA completion was maintained from weeks 1 to 3 but significantly dropped at the fourth week. Patient acceptability feedback was generally positive; negative comments related primarily to technological problems.

Conclusions: This was the first study to use EMA in recently discharged patients with psychotic-spectrum disorders. EMA is feasible and acceptable in this population, but completion rates were lower than in more stable samples. Future research should consider limiting the assessment period, screening for substance use, and integrating assessment with intervention elements to increase EMA engagement.

Citing Articles

Fostering engagement using a wearable for self-tracking assisted psychotherapy with refugees diagnosed with complex PTSD: a feasibility pilot study.

Riisager L, Huniche L, Larsen J, Christiansen T, Kring L, Palic S Front Psychiatry. 2025; 16:1250552.

PMID: 40078522 PMC: 11897709. DOI: 10.3389/fpsyt.2025.1250552.


Exploring the utility of N-acetylcysteine for loss of control eating: protocol of an open-label single-arm pilot study.

Muthmainah M, Sketriene D, Anversa R, Harris E, Griffiths S, Gogos A Pilot Feasibility Stud. 2025; 11(1):19.

PMID: 39972374 PMC: 11837714. DOI: 10.1186/s40814-025-01598-5.


Feasibility, acceptability and preliminary clinical outcomes of a brief coping-focused intervention for delusions blended with smartphone-based ecological momentary assessment and intervention in persons with schizophrenia spectrum disorders: A....

Boge K, Bergmann N, Hahne I, Emde L, Cartner S, Bell I Internet Interv. 2025; 39:100804.

PMID: 39944241 PMC: 11816215. DOI: 10.1016/j.invent.2025.100804.


Barriers and Facilitators of User Engagement With Digital Mental Health Interventions for People With Psychosis or Bipolar Disorder: Systematic Review and Best-Fit Framework Synthesis.

Eisner E, Faulkner S, Allan S, Ball H, Di Basilio D, Nicholas J JMIR Ment Health. 2025; 12:e65246.

PMID: 39832352 PMC: 11791459. DOI: 10.2196/65246.


The day-to-day influence of trauma exposure and sleep dysfunction on everyday stress in youth at familial high-risk for psychotic disorders.

Haudrich E, Burns E, Gupta T, Haas G, Horton L Schizophr Res. 2024; 274:535-544.

PMID: 39586206 PMC: 11803678. DOI: 10.1016/j.schres.2024.10.024.


References
1.
Bush K, Kivlahan D, McDonell M, Fihn S, Bradley K . The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998; 158(16):1789-95. DOI: 10.1001/archinte.158.16.1789. View

2.
Serre F, Fatseas M, Debrabant R, Alexandre J, Auriacombe M, Swendsen J . Ecological momentary assessment in alcohol, tobacco, cannabis and opiate dependence: a comparison of feasibility and validity. Drug Alcohol Depend. 2012; 126(1-2):118-23. DOI: 10.1016/j.drugalcdep.2012.04.025. View

3.
McGrath J, Saha S, Chant D, Welham J . Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008; 30:67-76. DOI: 10.1093/epirev/mxn001. View

4.
Oorschot M, Lataster T, Thewissen V, Wichers M, Myin-Germeys I . Mobile assessment in schizophrenia: a data-driven momentary approach. Schizophr Bull. 2011; 38(3):405-13. PMC: 3330000. DOI: 10.1093/schbul/sbr166. View

5.
Miller B, Stewart A, Schrimsher J, Peeples D, Buckley P . How connected are people with schizophrenia? Cell phone, computer, email, and social media use. Psychiatry Res. 2015; 225(3):458-63. DOI: 10.1016/j.psychres.2014.11.067. View